|
RHÖN-KLINIKUM Aktiengesellschaft
05.03.2020 / 17:46
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
|
Name:
|
RHÖN-KLINIKUM Aktiengesellschaft
|
|
Street:
|
Salzburger Leite 1
|
|
Postal code:
|
97616
|
|
City:
|
Bad Neustadt a.d.Saale
Germany
|
|
Legal Entity Identifier (LEI):
|
529900MVGMIVUDQY9E20
|
2. Reason for notification
|
|
Acquisition/disposal of shares with voting rights
|
|
X
|
Acquisition/disposal of instruments
|
|
|
Change of breakdown of voting rights
|
|
|
Other reason:
|
3. Details of person subject to the notification obligation
Natural person (first name, surname):
Dr. Bernard
große Broermann
Date of birth:
20 Nov 1943
|
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Asklepios Kliniken GmbH & Co. KGaA
|
5. Date on which threshold was crossed or reached:
6. Total positions
|
|
% of voting rights attached to shares
(total of 7.a.)
|
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
|
Total of both in %
(7.a. + 7.b.)
|
Total number of voting rights pursuant to Sec. 41 WpHG
|
|
New
|
28.99 %
|
49.77 %
|
50.07 %
|
66962470
|
|
Previous notification
|
28.99 %
|
48.69 %
|
48.99 %
|
/
|
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
|
ISIN
|
Absolute
|
In %
|
|
|
Direct
(Sec. 33 WpHG)
|
Indirect
(Sec. 34 WpHG)
|
Direct
(Sec. 33 WpHG)
|
Indirect
(Sec. 34 WpHG)
|
|
DE0007042301
|
360
|
19415354
|
0.0005 %
|
28.99 %
|
|
Total
|
19415714
|
28.99 %
|
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
|
Type of instrument
|
Expiration or maturity date
|
Exercise or conversion period
|
Voting rights absolute
|
Voting rights in %
|
|
|
|
|
|
%
|
|
|
|
Total
|
|
%
|
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
|
Type of instrument
|
Expiration or maturity date
|
Exercise or conversion period
|
Cash or physical settlement
|
Voting rights absolute
|
Voting rights in %
|
|
right to transfer shares under share purchase agreement of 28 February 2020 subject to a condition precedent
|
|
|
|
8294407
|
12.39 %
|
|
right to transfer shares under share purchase agreement of 1 March 2020 subject to a condition precedent
|
|
|
|
722860
|
1.08 %
|
|
contribution obligation subject to a condition precedent under joint venture agreement
|
|
|
|
33324466
|
49.77 %
|
|
|
|
|
Total
|
33324466
|
49.77 %
|
8. Information in relation to the person subject to the notification obligation
|
|
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
|
|
X
|
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
|
|
Name
|
% of voting rights (if at least 3% or more)
|
% of voting rights through instruments (if at least 5% or more)
|
Total of both (if at least 5% or more)
|
|
Dr. Bernard große Broermann
|
%
|
%
|
%
|
|
Asklepios Kliniken Management GmbH
|
%
|
%
|
%
|
|
Asklepios Kliniken GmbH & Co. KGaA
|
28.69 %
|
%
|
28.69 %
|
|
AMR Holding GmbH i.G.
|
%
|
49.77 %
|
49.77 %
|
|
|
|
|
|
|
Dr. Bernard große Broermann
|
%
|
%
|
%
|
|
Broermann Holding GmbH
|
%
|
%
|
%
|
|
Asklepios Kliniken GmbH & Co. KGaA
|
28.69 %
|
%
|
28.69 %
|
|
AMR Holding GmbH i.G.
|
%
|
49.77 %
|
49.77 %
|
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
|
Proportion of voting rights
|
Proportion of instruments
|
Total of both
|
|
%
|
%
|
%
|
10. Other explanatory remarks:
|
On 28 February 2020, Asklepios Kliniken GmbH & Co. KGaA (“Asklepios”) concluded a purchase agreement, subject to a condition precedent, with Eugen and Ingeborg Münch for the acquisition of a 12.39% stake in RHÖN-KLINIKUM AG (“RHÖN”).
Asklepios has agreed in a joint venture agreement dated 28 February 2020, subject to a condition precedent, to contribute, after closing of the purchase agreements, Asklepios’ stake in RHÖN (as of 1 March 2020, taking the share purchase agreements into account: 42.15%) to AMR Holding GmbH i.G. (“AMR”). As this stake includes the 28.69% already held by Asklepios, voting rights and instruments are not aggregated in this amount. In addition, HCM SE has agreed to contribute a 7.61% stake in RHÖN to AMR subject to a condition precedent.
On 1 March 2020 Asklepios concluded a purchase agreement subject to a condition precedent for the acquisition of an additional 1.08% stake in RHÖN.
|
Date
05.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|